{"DataElement":{"publicId":"4419931","version":"1","preferredName":"Histology Liquid Tumor Information Descriptive Text","preferredDefinition":"Text to capture information about a hematological malignancy that may derive from either of the two major blood cell lineages: myeloid and lymphoid cell lines. A subgroup of them are more severe and are known as hematological malignancies or blood cancer, and may also be referred to as liquid tumors.","longName":"HIST_LQD_TUM_INF_TXT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"4419927","version":"1","preferredName":"Histology Liquid Tumor Information","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A malignant tumor that originates from myeloid or lymphoid cells i.e., leukemias and lymphomas._Knowledge derived from study, experience, or instruction that has been gathered or received by communication.","longName":"4419925v1.0:2710348v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"4419925","version":"1","preferredName":"Histology Liquid Tumor","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:A malignant tumor that originates from myeloid or lymphoid cells i.e., leukemias and lymphomas.","longName":"C16681:C116915","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Liquid Tumor","conceptCode":"C116915","definition":"A malignant tumor that originates from myeloid or lymphoid cells i.e., leukemias and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF6EB603-0DA2-3DD7-E040-BB89AD4370CB","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"ONEDATA","dateModified":"2014-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2710348","version":"1","preferredName":"Information","preferredDefinition":"Knowledge derived from study, experience, or instruction that has been gathered or received by communication.","longName":"C48191","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Information","conceptCode":"C48191","definition":"Knowledge derived from study, experience, or instruction that has been gathered or received by communication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40A6057C-42CB-38D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-06","endDate":null,"createdBy":"UMLLOADER_JHUPROTDB","dateCreated":"2007-12-06","modifiedBy":"ONEDATA","dateModified":"2007-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF6EB603-0DB0-3DD7-E040-BB89AD4370CB","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181231","version":"1","preferredName":"Descriptive Text","preferredDefinition":"The text that provides a description of a topic.","longName":"DESCR_TXT","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"ALPHANUMERIC","minLength":"1","maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D3B72801-8C4C-3772-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2004-02-19","modifiedBy":"GDEEN","dateModified":"2022-05-31","changeDescription":"3/22/22 jk added \"Qualified\" RS as part of MCL quarterly content review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Liquid tumors","type":"Preferred Question Text","description":"Liquid tumors","url":null,"context":"CTEP"}],"origin":"CTEP:Cancer Therapy Evaluation Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF6EB603-0DC1-3DD7-E040-BB89AD4370CB","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup; Curated to support the NCI CTEP Exceptional Responders clinical trial. 7.30.2014 dmr.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}